| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
Methyl β-D-glucopyranoside does not have a specific therapeutic target but serves as a model compound for studying glycosidic bonds and carbohydrate interactions. It is a substrate for glycosidases and glycosyltransferases and is used to study enzyme specificity and carbohydrate metabolism. Its role as a glycoside makes it a valuable tool for studying the chemistry and biology of carbohydrates. It does not have significant pharmacological activity.
|
|---|---|
| ln Vitro |
In vitro, Methyl β-D-glucopyranoside is used as a model compound in studies of glycosidic bonds and carbohydrate interactions. It is used to synthesize natural glycophenolics via enzymatic caffeoylation. It can be used in organic synthesis and biocatalysis research. Its primary activity is as a chemical reagent, not as a pharmacologically active compound.
|
| ln Vivo |
In vivo, Methyl β-D-glucopyranoside is metabolized to glucose and methanol. It is not used as a therapeutic agent. Its application is primarily in research and as a sugar substitute.
|
| Enzyme Assay |
In vitro non-cell assays for Methyl β-D-glucopyranoside are not applicable, as it is a chemical reagent. Its properties are assessed using analytical techniques such as NMR or HPLC to determine its purity and structure.
|
| Cell Assay |
In vitro cell-based assays for Methyl β-D-glucopyranoside are limited, as it is not a drug. It may be used in studies of carbohydrate metabolism and glycosidase activity, but specific data are not detailed.
|
| Animal Protocol |
In vivo animal studies for Methyl β-D-glucopyranoside are not typically performed, as it is not a therapeutic agent.
|
| ADME/Pharmacokinetics |
Methyl β-D-glucopyranoside has a molecular weight of 194.18 g/mol and a molecular formula of C₇H₁₄O₆. Its IUPAC name is (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol. The compound has a melting point of 111-113°C. It should be stored under appropriate conditions, typically at room temperature, protected from moisture.
|
| Toxicity/Toxicokinetics |
Methyl β-D-glucopyranoside is generally recognized as safe (GRAS) as a food ingredient. It is non-toxic at normal dietary levels. Standard laboratory safety precautions should be followed when handling the compound.
|
| Additional Infomation |
Methyl β-D-glucopyranoside is a β-D-glucopyranoside with a methyl substituent at the terminal carbon atom. It is both a β-D-glucopyranoside and a methyl D-glucopyranoside. It has been reported to exist in Rosa laevigata, Pedicularis plicata, and other organisms with relevant data.
Methyl β-D-glucopyranoside is a carbohydrate derivative used in biochemical research and as a model compound for studying glycosidic bonds. It is used in organic synthesis and biocatalysis research. Not a drug; used as a research reagent and sugar substitute. |
| Molecular Formula |
C7H14O6
|
|---|---|
| Molecular Weight |
194.1825
|
| Exact Mass |
194.079
|
| CAS # |
709-50-2
|
| PubChem CID |
445238
|
| Appearance |
White to off-white solid powder
|
| Density |
1.5±0.1 g/cm3
|
| Boiling Point |
389.1±42.0 °C at 760 mmHg
|
| Melting Point |
107-111ºC
|
| Flash Point |
189.1±27.9 °C
|
| Vapour Pressure |
0.0±2.0 mmHg at 25°C
|
| Index of Refraction |
1.548
|
| LogP |
-2.69
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
13
|
| Complexity |
163
|
| Defined Atom Stereocenter Count |
5
|
| SMILES |
O1[C@]([H])([C@@]([H])([C@]([H])([C@@]([H])([C@@]1([H])C([H])([H])O[H])O[H])O[H])O[H])OC([H])([H])[H]
|
| InChi Key |
HOVAGTYPODGVJG-XUUWZHRGSA-N
|
| InChi Code |
InChI=1S/C7H14O6/c1-12-7-6(11)5(10)4(9)3(2-8)13-7/h3-11H,2H2,1H3/t3-,4-,5+,6-,7-/m1/s1
|
| Chemical Name |
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~250 mg/mL (~1287.47 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 20 mg/mL (103.00 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.1499 mL | 25.7493 mL | 51.4986 mL | |
| 5 mM | 1.0300 mL | 5.1499 mL | 10.2997 mL | |
| 10 mM | 0.5150 mL | 2.5749 mL | 5.1499 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.